Treatment failure of low molecular weight heparin bridging therapy before a cardiac surgery intervention in a patient with atrial fibrillation.
From time to time, it may be necessary to interrupt oral anticoagulant therapy in preparation for surgical procedures. In high-risk patients or for longer periods, unfractionated or low-molecular-weight heparin bridging treatment has been reported safe. This case focuses attention on treatment failure of low molecular weight heparin bridging therapy in a patient with atrial fibrillation.
Salvatore
S
Patanè
Filippo
F
Marte
Giuseppe
G
Risica
Laura
L
Giannetto
Felice Carmelo
FC
La Rosa
Roberto
R
La Rocca
Giuseppe
G
Dattilo
Mauro
M
Sturiale
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000601:surgery; D006348:Cardiac Surgical Procedures; D004452:Echocardiography; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D008946:Mitral Valve Stenosis / Q000601:surgery; D014057:Tomography, X-Ray Computed; D017211:Treatment Failure
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight